Drugplain

BRINZOLAMIDE 10 mg/mL

brinzolamide · SUSPENSION/ DROPS · Bausch & Lomb Incorporated

No Recall History
Plain English

BRINZOLAMIDE is a suspension/ drops containing brinzolamide at 10 mg/mL, taken ophthalmic. Manufactured by Bausch & Lomb Incorporated.

Key Facts

Brand Name
BRINZOLAMIDE
Generic Name
brinzolamide
NDC Code (Product)
24208-464
Manufacturer
Bausch & Lomb Incorporated
Strength
10 mg/mL
Dosage Form
SUSPENSION/ DROPS
Route
OPHTHALMIC
Marketing Status
Application #
ANDA204884
Drug Class
Carbonic Anhydrase Inhibitor [EPC]
Marketing Start
03/31/2022

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

dizziness313 reports
dyspnoea300 reports
fall272 reports
eye pain267 reports
diarrhoea262 reports
pruritus249 reports
arthralgia248 reports
headache241 reports
malaise240 reports
haemorrhagic stroke239 reports

Frequently Asked Questions

What is BRINZOLAMIDE used for?

BRINZOLAMIDE contains brinzolamide. It is a suspension/ drops taken ophthalmic. Consult your doctor for specific uses.

Is BRINZOLAMIDE a controlled substance?

BRINZOLAMIDE is not classified as a controlled substance by the DEA.

What is the generic name for BRINZOLAMIDE?

The generic name for BRINZOLAMIDE is brinzolamide. There are 3 other brand versions of brinzolamide.

What is the NDC code for BRINZOLAMIDE 10 mg/mL?

The NDC (National Drug Code) for BRINZOLAMIDE 10 mg/mL is 24208-464, listed by Bausch & Lomb Incorporated.

Product NDC

24208-464

Package NDC

24208-464-10

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)